Parkinson's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Parkinson's Disease, including details on symptoms, treatment, genetics, medication.

Volume 3 (2006), Issue 8 (August)

1. Alexithymia in Parkinson's disease is related to severity of depressive symptoms.
   Eur J Neurol, 13(8): 836-41. [Abstract] [Full-text]
2. Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study.
   Neurology, 67(3): 494-6. [Abstract] [Full-text]
3. When do patients with Parkinson disease disclose their diagnosis?
   Neurology, 67(3): 488-90. [Abstract] [Full-text]
4. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
   JAMA, 296(6): 661-70. [Abstract] [Full-text]
5. Clinical features and gene analysis in Korean patients with early-onset Parkinson disease.
   Arch Neurol, 63(8): 1170-4. [Abstract] [Full-text]
6. Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor?
   Arch Neurol, 63(8): 1100-4. [Abstract] [Full-text]
7. Subthalamic stimulation in Parkinson disease: behavior and social adaptation.
   Arch Neurol, 63(8): 1090-5. [Abstract] [Full-text]
8. alpha-synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy.
   Neurosci Lett, 405(3): 223-5. [Abstract] [Full-text]
9. Correlation of tau gene polymorphism with age at onset of Parkinson's disease.
   Neurosci Lett, 405(3): 202-6. [Abstract] [Full-text]
10. Association study of sporadic Parkinson's disease genetic risk factors in patients from Russia by APEX technology.
    Neurosci Lett, 405(3): 212-6. [Abstract] [Full-text]
11. The mystery of motor asymmetry in Parkinson's disease.
    Lancet Neurol, 5(9): 796-802. [Abstract] [Full-text]
12. Atypical antipsychotics in the elderly with Parkinson disease and the "black box" warning.
    Neurology, 67(4): 564-6. [Abstract] [Full-text]
13. Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease.
    Neurology, 67(4): 697-9. [Abstract] [Full-text]
14. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.
    J Cereb Blood Flow Metab, 26(9): 1198-212. [Abstract] [Full-text]
15. Major and minor depression in Parkinson's disease: a neuropsychological investigation.
    Eur J Neurol, 13(9): 972-80. [Abstract] [Full-text]
16. Side-effects of subthalamic stimulation in Parkinson's disease: clinical evolution and predictive factors.
    Eur J Neurol, 13(9): 963-71. [Abstract] [Full-text]
17. The safety and feasibility of high-force eccentric resistance exercise in persons with Parkinson's disease.
    Arch Phys Med Rehabil, 87(9): 1280-2. [Abstract] [Full-text]
18. Nuclear localization of the 20S proteasome subunit in Parkinson's disease.
    Neurosci Lett, 406(1): 43-8. [Abstract] [Full-text]
19. Step initiation in Parkinson's disease: influence of initial stance conditions.
    Neurosci Lett, 406(1): 128-32. [Abstract] [Full-text]
20. Emerging drugs for Parkinson's disease.
    Expert Opin Emerg Drugs, 11(3): 403-17. [Abstract] [Full-text]
21. A randomized trial of deep-brain stimulation for Parkinson's disease.
    N Engl J Med, 355(9): 896-908. [Abstract] [Full-text]

© 2004-2008 Parkinson's Disease Research Today. All Rights Reserved.